Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection

BACKGROUND: Infection with HIV-1 results in marked immunologic insults and structural damage to the intestinal mucosa, including compromised barrier function. While the development of highly active antiretroviral therapy (HAART) has been a major advancement in the treatment of HIV-1 infection, the n...

Descripción completa

Detalles Bibliográficos
Autores principales: Schunter, Marco, Chu, Hiutung, Hayes, Timothy L, McConnell, Delandy, Crawford, Sean S, Luciw, Paul A, Bengmark, Stig, Asmuth, David M, Brown, Jennifer, Bevins, Charles L, Shacklett, Barbara L, Critchfield, J William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3414771/
https://www.ncbi.nlm.nih.gov/pubmed/22747752
http://dx.doi.org/10.1186/1472-6882-12-84

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3414771/
https://www.ncbi.nlm.nih.gov/pubmed/22747752
http://dx.doi.org/10.1186/1472-6882-12-84

Ejemplares similares